Personalis Inc

Research Personalis Inc (PSNL) on Bullrun: market cap USD 1.44B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerPSNL
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDiagnostics & Research
• CurrencyUSD
• Market capUSD 1.44B
• Financial periodFY2025
• RevenueUSD 69.65M
• Revenue growth-17.7%
• Net income-USD 81.27M
• Free cash flow-USD 79.45M
• Gross margin22.7%

Valuation Snapshot

latest market cap is USD 1.44B.

About Personalis Inc

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers;

Frequently asked questions

What is Personalis Inc's market cap?

Personalis Inc's market capitalization is USD 1.44B.

What does Personalis Inc do?

Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally.